A A A

Nomination guidelines

The nomination deadline is Wednesday, December 2, 2020 at 5pm ET.

Download the full nomination guide here.

Candidates may be nominated for one award, plus the CCS Inclusive Excellence Prize. Candidates can also be nominated for the CCS Inclusive Excellence Prize alone.

For the Lifetime Contribution, Robert L. Noble, O. Harold Warwick, Bernard and Francine Dorval, and William E. Rawls Prizes, each nomination must include:

1. One nomination letter from an appropriate authority from the nominee’s host institution (nominator)
2. A reference letter from an individual from outside of the host institution who can attest to the impact of the nominee’s research/contributions (referee)
  • Note: for the Lifetime Contribution prize, this letter may be substituted with impact statements/testimonials from researchers who have benefitted from the nominee’s contributions detailing the impact these contributions have had on their own successes
3. A reference letter from a qualified expert in the nominee’s field who can attest to the international significance and impact of the nominee’s research program/contributions (referee)
4. A current curriculum vitae for the nominee including, but not limited to: honours and awards, publications, and grants held

The nomination letter (maximum 4 pages), reference letters (maximum 2 pages each) and impact statements/testimonials (maximum 3 pages total) must be submitted in PDF format, presented on official letterhead, dated and signed. Nominators and referees are to include a brief description of their credentials as well as their professional relationship with the applicant to put their recommendations into context. 

The three (3) letters should collectively contain the following information:
  • for early career investigators - the nominator’s letter should include the start date of the candidate’s first independent academic career (contact CCS research staff for questions regarding eligibility) 
  • a concise description of the candidate’s contributions which could be used in a public citation for the award 
  • a detailed description of the candidate’s contributions to cancer/cancer research in Canada and internationally where relevant
  • if the candidate’s research/contributions have had a direct impact on the treatment or management of cancer, indicate the actual or potential benefits to the Canadian public, and internationally where applicable 
  • the candidate’s research productivity in terms of scholarly contributions, research funding track record and forged collaborations in Canada and internationally where applicable. Highlight any publications in the individual’s CV which you believe are particularly noteworthy
  • highlight service to the research community and/or the Canadian Cancer Society and/or evidence of outreach efforts to the general public 
  • regarding consideration of circumstances which may have impacted the nominee’s career (see evaluation criteria below) – where possible, any barriers should be explained
  • awardees may be asked by CCS to function as spokespersons about the importance of cancer research to the public. The nominator should address the candidate's ability, preferably with concrete examples, to be an "ambassador" for cancer research generally, and for the Canadian Cancer Society as appropriate.

Please submit nominations by Wednesday, December 2, 2020 at 5pm ET via the online form.

Renominations

We encourage renominations where eligible. Packages are valid for up to 3 consecutive nomination years, but must be re-submitted by completing the renomination form and providing an updated CV. Other documents may be updated as desired (to reflect new contributions). Please ensure that submissions for nominees to the early career investigator awards remain eligible within the 10 year award window (i.e. December 31, 2009).

Please submit renominations by Wednesday, December 2, 2020 at pm ET via the online form.

For the Inclusive Excellence Prize, each nomination must include:   

1. One nomination letter from an individual who has firsthand knowledge of the nominee’s efforts in the advancement of equity, diversity and inclusion in the cancer research ecosystem in Canada (nominator)
2. Two reference letters from individuals who have directly observed or benefitted from the nominee’s leadership in fostering inclusive excellence (referees)

  • Note: one or more of the letters may also consist of a series of impact statements/testimonials from individuals whose career trajectories, research programs, etc. have been impacted directly by the efforts of the individual.

3. A current curriculum vitae for the nominee

The nomination letter (maximum 4 pages), reference letters (maximum 2 pages) and impact statements/testimonials (maximum 3 pages if combined with 1 reference letter, or 6 pages if not) must be submitted in PDF format, presented on official letterhead (as applicable), dated and signed. Contributors are to include a brief description of their credentials / relationship with the applicant to put their comments into context. 

The letters/statements/testimonials should collectively contain the following information:

  • a concise description of the candidate’s contributions which could be used in a public citation for the award
  • a detailed description of the candidate’s efforts/actions towards fostering inclusive excellence in Canada’s cancer research ecosystem
  • a detailed account of the specific impact(s) on Canada’s cancer research ecosystem diversity
  • evidence (if applicable) that the candidate is viewed as an equity, diversity and inclusion leader in Canada
  • note that the nominee does not necessarily have to be a cancer researcher themselves

Please submit nominations by December 2, 2020 at 5pm ET via the online form.  

If you need assistance, please contact:

Sherri Huys
Administrator, Grants and Programs
E-mail: sherri.huys@cancer.ca


Last modified on: May 12, 2021